ONC
The table below shows BeOne Medicines AG's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $4.55B | $2.63B | $3.17B | $3.87B | $4.38B | $1.38B |
| Short-term investments | - | - | $2.60M | $665.25M | $2.24B | $3.27B |
| Receivables | $865.08M | $676.28M | $358.03M | $173.17M | $483.11M | $60.40M |
| Inventory | $608.23M | $494.99M | $416.12M | $282.35M | $242.63M | $89.29M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $6.23B |
| $3.99B |
| $4.20B |
| $5.21B |
| $7.61B |
| $4.96B |
| Property, plant & equipment | $1.64B | $1.58B | $1.32B | $845.95M | $587.61M | $357.69M |
| Goodwill | - | - | - | $109.00K | $109.00K | $109.00K |
| Total assets | $8.19B | $5.92B | $5.81B | $6.38B | $8.65B | $5.60B |
| Accounts payable | $479.04M | $405.00M | $315.11M | $294.78M | $262.40M | $231.96M |
| Total current liabilities | $1.83B | $2.21B | $1.81B | $1.47B | $1.60B | $1.08B |
| Long-term debt | $961.91M | $166.48M | $197.62M | $209.15M | $202.11M | $183.64M |
| Total liabilities | $3.83B | $2.59B | $2.27B | $2.00B | $2.40B | $1.73B |
| Retained earnings | -$8.32B | -$8.61B | -$7.96B | -$7.08B | -$4.97B | -$3.55B |
| Total equity | $4.36B | $3.33B | $3.54B | $4.38B | $6.24B | $3.87B |